FIELD: biotechnology.
SUBSTANCE: invention relates to the peptide, the HIR-Fab-IDS compound, as well as to a composition containing it.
EFFECT: invention is effective for the prevention or treatment of lysosomal enzyme deficiency in a subject having a lysosomal storage disease.
21 cl, 8 dwg, 7 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUND CONTAINING THERAPEUTIC ENZYME AND TRANSPORT ELEMENT CONNECTED TO EACH OTHER DIRECTLY OR BY USING LINKER | 2022 |
|
RU2811100C1 |
ANTIBODIES CONTAINING POLYPEPTIDE INTEGRATED INTO FRAME REGION 3 | 2019 |
|
RU2796254C2 |
LACTASE ENZYMES WITH IMPROVED ACTIVITY AT LOW TEMPERATURES | 2018 |
|
RU2800427C2 |
ANTIBODY AND DRUG CONJUGATES FOR DESTRUCTION OF HEMATOPOIETIC STEM CELLS | 2017 |
|
RU2781444C2 |
PSEUDO-FAB BASED MULTISPECIFIC BINDING PROTEINS | 2019 |
|
RU2820254C2 |
METHOD FOR PRODUCING A POLYPEPTIDE HETEROMULTIMER | 2014 |
|
RU2758952C1 |
METHOD OF PRODUCING A POLYPEPTIDE HETEROMULTITERS | 2014 |
|
RU2730594C2 |
PROTEINS BINDING NKG2D, CD16 AND TUMOUR-ASSOCIATED ANTIGEN | 2018 |
|
RU2816716C2 |
ANTIBODIES SUITABLE FOR PASSIVE IMMUNIZATION AGAINST INFLUENZA, AND COMPOSITIONS THEREOF, COMBINATIONS AND METHODS OF USING | 2015 |
|
RU2720282C1 |
MOLECULES BINDING WITH CD38 AND PD-L1 | 2017 |
|
RU2764201C2 |
Authors
Dates
2024-02-28—Published
2023-02-21—Filed